Circulation Research, Vol 69, 370-377, Copyright © 1991 by American Heart Association

ARTICLES

Contribution of endogenous endothelin to the extension of myocardial infarct size in rats

T Watanabe, N Suzuki, N Shimamoto, M Fujino and A Imada
Biology Research Laboratories, Takeda Chemical Industries, Ltd., Osaka, Japan.

Pathophysiological roles of endogenous endothelin have been studied from the viewpoint of its contribution to the extension of myocardial infarct size. A monoclonal antibody against endothelin 1 (AwETN40) suppressed changes induced by endothelin 1 and endothelin 2 but did not modify those by endothelin 3 in vivo or in vitro. Effects of AwETN40 on myocardial infarct size were investigated. Coronary ligation (1 hour) and reperfusion (24 hours) in rats caused infarction in 35% of the left ventricle. Repetitive or single administration of AwETN40 reduced the infarct size; an intravenous injection of 22.5 mg/kg of the antibody 5 minutes after coronary occlusion or 5 minutes before reperfusion reduced the size by 38% or 31% of the control, respectively. Plasma and tissue endothelin 1 and plasma big endothelin 1 in rats were measured at various stages after occlusion. Plasma endothelin 1 showed a fourfold increase 10 minutes after reperfusion (from 1.02 to 3.96 pg/ml) and had returned to the control value after 8 hours. Plasma big endothelin 1 showed changes similar to those of plasma endothelin 1. No significant changes in plasma endothelin 2 and endothelin 3 were observed. Cardiac tissue contained seven times as much endothelin 1 as the control value 1 hour after reperfusion (4.59 versus 33.1 pg/g tissue), and a high concentration (13.2 pg/g tissue) was maintained even after 48 hours. We concluded that an increase in endogenous endothelin 1 plays an important role in the extension of myocardial infarct size.

This article has been cited by other articles:

				S. Tamareille, H. Achour, J. Amirian, P. Felli, R. J. Bick, B. Poindexter, Y. J. Geng, W. H. Barry, and R. W. Smalling Left ventricular unloading before reperfusion reduces endothelin-1 release and calcium overload in porcine myocardial infarction. J. Thorac. Cardiovasc. Surg., August 1, 2008; 136(2): 343 - 351. [Abstract] [Full Text] [PDF]

				G. G. Baltogiannis, D. G. Tsalikakis, A. C. Mitsi, K. E. Hatzistergos, D. Elaiopoulos, D. I. Fotiadis, Z. S. Kyriakides, and T. M. Kolettis Endothelin receptor-A blockade decreases ventricular arrhythmias after myocardial infarction in rats Cardiovasc Res, September 1, 2005; 67(4): 647 - 654. [Abstract] [Full Text] [PDF]

				I. A. Khan Role of Endothelin-1 in Acute Myocardial Infarction Chest, May 1, 2005; 127(5): 1474 - 1476. [Full Text] [PDF]

				S. Yamamoto, N. Matsumoto, M. Kanazawa, M. Fujita, M. Takaoka, C. E. Gariepy, M. Yanagisawa, and Y. Matsumura Different Contributions of Endothelin-A and Endothelin-B Receptors in Postischemic Cardiac Dysfunction and Norepinephrine Overflow in Rat Hearts Circulation, January 25, 2005; 111(3): 302 - 309. [Abstract] [Full Text] [PDF]

				J. C. S. Tsui, D. M. Baker, E. Biecker, S. Shaw, and M. R. Dashwood Altered Endothelin-1 Levels in Acute Lower Limb Ischemia and Reperfusion Angiology, September 1, 2004; 55(5): 533 - 539. [Abstract] [PDF]

				Q.-D. Wang, J. Pernow, P.-O. Sjoquist, and L. Ryden Pharmacological possibilities for protection against myocardial reperfusion injury Cardiovasc Res, July 1, 2002; 55(1): 25 - 37. [Abstract] [Full Text] [PDF]

				A. T. Goodwin, R. T. Smolenski, C. C. Gray, J. Jayakumar, M. Amrani, and M. H. Yacoub Role of endogenous endothelin on coronary reflow after cardioplegic arrest J. Thorac. Cardiovasc. Surg., December 1, 2001; 122(6): 1167 - 1173. [Abstract] [Full Text] [PDF]

				C. FERNANDEZ-PATRON, C. ZOUKI, R. WHITTAL, J. S. D. CHAN, S. T. DAVIDGE, and J. G. FILEP Matrix metalloproteinases regulate neutrophil-endothelial cell adhesion through generation of endothelin-1[1-32] FASEB J, October 1, 2001; 15(12): 2230 - 2240. [Abstract] [Full Text] [PDF]

				J. Pernow, A.T. Gonon, and A. Gourine The role of the endothelium for reperfusion injury Eur. Heart J. Suppl., June 1, 2001; 3(suppl_C): C22 - C27. [Abstract] [PDF]

				L. E. Spieker, G. Noll, F. T. Ruschitzka, and T. F. Luscher Endothelin receptor antagonists in congestive heart failure: a new therapeutic principle for the future? J. Am. Coll. Cardiol., May 1, 2001; 37(6): 1493 - 1505. [Abstract] [Full Text] [PDF]

				Z. S. Kyriakides, D. Th. Kremastinos, T. M. Kolettis, A. Tasouli, A. Antoniadis, and D. J. Webb Acute Endothelin-A Receptor Antagonism Prevents Normal Reduction of Myocardial Ischemia on Repeated Balloon Inflations During Angioplasty Circulation, October 17, 2000; 102(16): 1937 - 1943. [Abstract] [Full Text] [PDF]

				Y. Yeghiazarians, J. B. Braunstein, A. Askari, and P. H. Stone Unstable Angina Pectoris N. Engl. J. Med., January 13, 2000; 342(2): 101 - 114. [Full Text] [PDF]

				K. Ono, A. Matsumori, T. Shioi, Y. Furukawa, and S. Sasayama Contribution of Endothelin-1 to Myocardial Injury in a Murine Model of Myocarditis : Acute Effects of Bosentan, an Endothelin Receptor Antagonist Circulation, October 26, 1999; 100(17): 1823 - 1829. [Abstract] [Full Text] [PDF]

				S. Battistelli, M. Billi, G. Manasse, A. Vittoria, F. Roviello, and S. Forconi Behavior of Circulating Endothelin-1 in a Group of Patients with Acute Myocardial Infarction Angiology, August 1, 1999; 50(8): 629 - 638. [Abstract] [PDF]

				I. Sharif, K. A. Kane, and C. L. Wainwright Endothelin and ischaemic arrhythmias-antiarrhythmic or arrhythmogenic? Cardiovasc Res, September 1, 1998; 39(3): 625 - 632. [Abstract] [Full Text] [PDF]

				A. T Gonon, Q.-D. Wang, and J. Pernow The endothelin A receptor antagonist LU 135252 protects the myocardium from neutrophil injury during ischaemia/reperfusion Cardiovasc Res, September 1, 1998; 39(3): 674 - 682. [Abstract] [Full Text] [PDF]

				A. Ergul, K. Shoemaker, D. Puett, and R. L. Tackett Gender Differences in the Expression of Endothelin Receptors in Human Saphenous Veins In Vitro J. Pharmacol. Exp. Ther., May 1, 1998; 285(2): 511 - 517. [Abstract] [Full Text]

				C. R. Aversa, S. Oparil, J. Caro, H. Li, S.-D. Sun, Y.-F. Chen, M. R. Swerdel, T. M. Monticello, S. K. Durham, A. Minchenko, et al. Hypoxia stimulates human preproendothelin-1 promoter activity in transgenic mice Am J Physiol Lung Cell Mol Physiol, October 1, 1997; 273(4): L848 - L855. [Abstract] [Full Text] [PDF]

				J. Pernow and Q.-D. Wang Endothelin in myocardial ischaemia and reperfusion Cardiovasc Res, March 1, 1997; 33(3): 518 - 526. [Abstract] [PDF]

				M. Watanuki, M. Horie, K. Tsuchiya, K. Obayashi, and S. Sasayama Endothelin-1 inhibition of cardiac ATP-sensitive K+ channels via pertussis-toxin-sensitive G-proteins Cardiovasc Res, January 1, 1997; 33(1): 123 - 130. [Abstract] [Full Text] [PDF]

				T. Hiramatsu, J. Forbess, T. Miura, S. J. Roth, M. A. Cioffi MAT, and J. E. Mayer Jr Effects of Endothelin-1 and Endothelin-A Receptor Antagonist on Recovery After Hypothermic Cardioplegic Ischemia in Neonatal Lamb Hearts Circulation, November 1, 1995; 92(9): 400 - 404. [Abstract] [Full Text]

				J. Donckier, L. Stoleru, W. Hayashida, H. Van Mechelen, P. Selvais, L. Galanti, J.-P. Clozel, J.-M. Ketelslegers, and H. Pouleur Role of Endogenous Endothelin-1 in Experimental Renal Hypertension in Dogs Circulation, July 1, 1995; 92(1): 106 - 113. [Abstract] [Full Text]

				T. Tonnessen, A. Giaid, D. Saleh, P. A. Naess, M. Yanagisawa, and G. Christensen Increased In Vivo Expression and Production of Endothelin-1 by Porcine Cardiomyocytes Subjected to Ischemia Circ. Res., May 1, 1995; 76(5): 767 - 772. [Abstract] [Full Text]

				T. Nakahashi, K. Fukuo, T. Inoue, S. Morimoto, S. Hata, M. Yano, and T. Ogihara Endothelin-1 Enhances Nitric Oxide–Induced Cytotoxicity in Vascular Smooth Muscle Hypertension, April 1, 1995; 25(4): 744 - 747. [Abstract] [Full Text]